social-determinants-of-health
(6)
Jon Carter
Jon Carter is the CEO and Founder of Prado, an Austin-based technology platform that connects physicians, nutrition providers, and food businesses to make food function as medicine — unlocking $170 billion in pre-tax HSA/FSA dollars for medically tailored meals. Before Prado, Carter built a career spanning digital product leadership at Union Bank and Live Nation (where he ran eCommerce for 600+ artist brands including Jay-Z and Madonna), and CEO of Snap Kitchen. His father died from type 2 diabetes, and that loss transformed into a professional mission: eliminate the friction preventing food from operating as healthcare.
Rachel Munsie
Rachel Munsie is the CEO and co-founder of Ounce of Care (Ounce), a tech-enabled resident services platform that connects people living in affordable housing to public benefits, health and social care coordination, and community programming. A former Goldman Sachs banker and private equity investor who left MIT Sloan to help build home-health startup Tomorrow Health, she launched Ounce to close the gap between where people live and the care they can actually reach. In October 2023 the company raised $5.2M in seed funding led by Meridian Street Capital and Flare Capital, with backers including Chelsea Clinton's Metrodora Ventures, Hilton CEO Chris Nassetta, and Unite Us co-founder Taylor Justice.
Colby Takeda
Colby Takeda is the co-founder and CEO of Pear Suite, a digital health company that gives community health workers the software, billing tools, and data infrastructure to be recognized as a foundational part of the healthcare system. A fourth-generation Japanese American from O'ahu, registered community health worker, and former senior living executive, he built Pear Suite during the pandemic on Google Sheets and Typeform before turning it into a care navigation platform that supports thousands of frontline workers. In October 2025 the company raised a $7.6 million Series A led by Rock Health Capital to expand its reach into Medicaid and Medicare markets.
Maggie McCullough
Maggie McCullough is the CEO and founder of PolicyMap, the Philadelphia-based mapping and data-visualization platform she launched in 2008. A former White House budget-office staffer turned housing researcher, she built PolicyMap after struggling to fit maps and data into her own policy work, betting that anyone should be able to make a map as easily as they shop online. The platform now serves universities, banks, health systems, nonprofits and governments, layering thousands of public and proprietary datasets into one searchable map. In December 2023 the company closed a $3 million Series A led by its former parent, the Reinvestment Fund.
Robby Knight
Robby Knight is the co-founder and CEO of evermore (formerly Soda Health), a healthtech company that turns supplemental health benefits into a Smart Benefits platform connecting Medicare Advantage members, health plans, and retailers like CVS, Walgreens, and Kroger. A social worker by training who spent nearly eight years architecting consumer health at Walmart, Knight built the company on a simple frustration: people's first-order needs (food, OTC medicine, transportation) were being met through a patchwork of inefficient programs. evermore has raised roughly $100 million, including a $50M Series B led by General Catalyst in December 2024.
Toyin Ajayi
Toyin Ajayi is a board-certified family medicine physician and the co-founder and CEO of Cityblock Health, a New York-based company that builds neighborhood-rooted care for Medicaid and dually eligible patients - the people most health systems treat last. She co-founded the company out of Google's Sidewalk Labs in 2017, took the CEO seat in 2022, and has grown it into a roughly $6 billion business serving hundreds of thousands of members. Trained at Stanford, Cambridge, and King's College London, she practiced in safety-net hospitals and ran a clinic in Sierra Leone before deciding the system itself needed rebuilding. Her current obsession: making the most vulnerable patients the proving ground for AI in medicine.